AAPL   374.19 (+2.77%)
MSFT   210.86 (+2.23%)
AMZN   3,036.08 (+5.04%)
NVDA   392.54 (+2.09%)
CGC   16.97 (+3.16%)
BABA   238.78 (+6.79%)
TSLA   1,343.17 (+11.13%)
T   30.32 (+0.80%)
F   6.18 (+2.15%)
GILD   76.72 (+0.48%)
DIS   113.87 (+1.50%)
BAC   23.67 (+1.63%)
NFLX   493.62 (+3.51%)
BA   187.97 (+3.96%)
AAPL   374.19 (+2.77%)
MSFT   210.86 (+2.23%)
AMZN   3,036.08 (+5.04%)
NVDA   392.54 (+2.09%)
CGC   16.97 (+3.16%)
BABA   238.78 (+6.79%)
TSLA   1,343.17 (+11.13%)
T   30.32 (+0.80%)
F   6.18 (+2.15%)
GILD   76.72 (+0.48%)
DIS   113.87 (+1.50%)
BAC   23.67 (+1.63%)
NFLX   493.62 (+3.51%)
BA   187.97 (+3.96%)
AAPL   374.19 (+2.77%)
MSFT   210.86 (+2.23%)
AMZN   3,036.08 (+5.04%)
NVDA   392.54 (+2.09%)
CGC   16.97 (+3.16%)
BABA   238.78 (+6.79%)
TSLA   1,343.17 (+11.13%)
T   30.32 (+0.80%)
F   6.18 (+2.15%)
GILD   76.72 (+0.48%)
DIS   113.87 (+1.50%)
BAC   23.67 (+1.63%)
NFLX   493.62 (+3.51%)
BA   187.97 (+3.96%)
AAPL   374.19 (+2.77%)
MSFT   210.86 (+2.23%)
AMZN   3,036.08 (+5.04%)
NVDA   392.54 (+2.09%)
CGC   16.97 (+3.16%)
BABA   238.78 (+6.79%)
TSLA   1,343.17 (+11.13%)
T   30.32 (+0.80%)
F   6.18 (+2.15%)
GILD   76.72 (+0.48%)
DIS   113.87 (+1.50%)
BAC   23.67 (+1.63%)
NFLX   493.62 (+3.51%)
BA   187.97 (+3.96%)
Log in

NASDAQ:CLXTCalyxt Stock Price, Forecast & News

$5.06
+0.02 (+0.40 %)
(As of 07/6/2020 03:45 PM ET)
Add
Compare
Today's Range
$4.96
Now: $5.06
$5.19
50-Day Range
$3.87
MA: $4.86
$5.81
52-Week Range
$2.40
Now: $5.06
$11.52
Volume27,159 shs
Average Volume87,679 shs
Market Capitalization$167.18 million
P/E RatioN/A
Dividend YieldN/A
Beta2.41
Calyxt, Inc., a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for agriculture in the United States. It engages in the development of high oleic and low linolenic soybean product candidates; high fiber wheat; improved quality alfalfa product candidates; and cold storable and reduced browning potatoes. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was founded in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. operates as a subsidiary of Cellectis S.A.
Read More
Calyxt logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.1Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.72 out of 5 stars


Industry, Sector and Symbol

Industry Agricultural chemicals
Sub-IndustryN/A
Current SymbolNASDAQ:CLXT
CUSIPN/A
Phone651-683-2807

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.30 million
Book Value$1.90 per share

Profitability

Net Income$-39,610,000.00
Net Margins-455.07%

Miscellaneous

Employees50
Market Cap$167.18 million
Next Earnings Date8/4/2020 (Estimated)
OptionableNot Optionable

Receive CLXT News and Ratings via Email

Sign-up to receive the latest news and ratings for CLXT and its competitors with MarketBeat's FREE daily newsletter.

Calyxt (NASDAQ:CLXT) Frequently Asked Questions

How has Calyxt's stock been impacted by COVID-19 (Coronavirus)?

Calyxt's stock was trading at $3.34 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CLXT stock has increased by 51.5% and is now trading at $5.06. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Calyxt?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Calyxt in the last year. There are currently 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Calyxt.

When is Calyxt's next earnings date?

Calyxt is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Calyxt.

How were Calyxt's earnings last quarter?

Calyxt Inc (NASDAQ:CLXT) released its earnings results on Thursday, May, 7th. The company reported ($0.34) EPS for the quarter, missing the Zacks' consensus estimate of ($0.33) by $0.01. The firm had revenue of $2.38 million for the quarter. Calyxt had a negative net margin of 455.07% and a negative return on equity of 64.78%. View Calyxt's earnings history.

What price target have analysts set for CLXT?

5 equities research analysts have issued 1 year price targets for Calyxt's shares. Their forecasts range from $4.00 to $10.00. On average, they anticipate Calyxt's stock price to reach $7.00 in the next year. This suggests a possible upside of 38.3% from the stock's current price. View analysts' price targets for Calyxt.

Has Calyxt been receiving favorable news coverage?

Media coverage about CLXT stock has been trending negative on Monday, InfoTrie reports. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Calyxt earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news about Calyxt.

Are investors shorting Calyxt?

Calyxt saw a decline in short interest in the month of June. As of June 30th, there was short interest totaling 256,900 shares, a decline of 5.2% from the June 15th total of 271,100 shares. Based on an average trading volume of 78,100 shares, the short-interest ratio is currently 3.3 days. Currently, 2.5% of the shares of the stock are sold short. View Calyxt's Current Options Chain.

Who are some of Calyxt's key competitors?

What other stocks do shareholders of Calyxt own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Calyxt investors own include Cellectis (CLLS), Ring Energy (REI), Ring Energy (REI), Cypress Semiconductor (CY), Molecular Templates (MTEM), AbbVie (ABBV), Advanced Micro Devices (AMD), Eaton (ETN), GW Pharmaceuticals PLC- (GWPH) and Intel (INTC).

Who are Calyxt's key executives?

Calyxt's management team includes the following people:
  • Mr. James A. Blome, Chief Exec. Officer (Age 56)
  • Dr. Daniel Voytas Ph.D., Founder & Chief Science Officer (Age 56)
  • Mr. Manoj Sahoo, Chief Commercial Officer (Age 44)
  • Mr. William F. Koschak, Chief Financial Officer (Age 50)
  • Mr. Eric Dutang, Principal Accounting Officer (Age 45)

When did Calyxt IPO?

(CLXT) raised $101 million in an initial public offering on Thursday, July 20th 2017. The company issued 6,100,000 shares at a price of $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities acted as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers.

What is Calyxt's stock symbol?

Calyxt trades on the NASDAQ under the ticker symbol "CLXT."

How do I buy shares of Calyxt?

Shares of CLXT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Calyxt's stock price today?

One share of CLXT stock can currently be purchased for approximately $5.06.

How big of a company is Calyxt?

Calyxt has a market capitalization of $167.18 million and generates $7.30 million in revenue each year. The company earns $-39,610,000.00 in net income (profit) each year or ($1.21) on an earnings per share basis. Calyxt employs 50 workers across the globe.

What is Calyxt's official website?

The official website for Calyxt is www.calyxt.com.

How can I contact Calyxt?

Calyxt's mailing address is 2800 MOUNT RIDGE ROAD, ROSEVILLE MN, 55113. The company can be reached via phone at 651-683-2807 or via email at [email protected]

This page was last updated on 7/6/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.